Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML. — المؤلف: Basheer, Faisal — The Journal of experimental medicine 20200505
- المؤلف
- Basheer, Faisal
- النشر
- The Journal of experimental medicine 20200505
- الوصف
- 966-981 p.
- الموضوعات
- Animals؛ Bone Marrow Cells؛ Bone Marrow Transplantation؛ Cell Line, Tumor؛ Cohort Studies؛ Disease Models, Animal؛ Disease Progression؛ Enhancer of Zeste Homolog 2 Protein